Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Sunil Pati is active.

Publication


Featured researches published by Sunil Pati.


Journal of Clinical Microbiology | 2008

Cytomegalovirus Strain Diversity in Seropositive Women

Zdenek Novak; Shannon A. Ross; Raj Kumar Patro; Sunil Pati; Rekha A. Kumbla; Sallie Brice; Suresh B. Boppana

ABSTRACT Infection and reinfection with multiple cytomegalovirus (CMV) strains have been shown to occur in immunocompromised individuals, sexually transmitted disease clinic attendees, and children attending day care centers. To characterize the CMV diversity in healthy seropositive individuals, 16 CMV PCR-positive specimens from 113 seropositive women were analyzed for glycoprotein gN and gB genotypes by cloning, followed by nucleotide sequencing of the plasmid DNA and/or restriction fragment length polymorphism (RFLP). The results showed that most (93.7%) of the PCR-positive specimens contained multiple gN and/or gB genomic variants, suggesting that the majority of women were infected with more than one virus strain. The results also showed that the RFLP technique might not be sufficiently sensitive to detect all of the genomic variants present in a sample.


The Journal of Infectious Diseases | 2011

Mixed Infection and Strain Diversity in Congenital Cytomegalovirus Infection

Shannon A. Ross; Zdenek Novak; Sunil Pati; Raj Kumar Patro; Jennifer Blumenthal; Vishwanath R. Danthuluri; Amina Ahmed; Marian G. Michaels; Pablo J. Sánchez; David I. Bernstein; Robert W. Tolan; April L. Palmer; William J. Britt; Karen B. Fowler; Suresh B. Boppana

BACKGROUND Cytomegalovirus (CMV), the most common cause of congenital infection, exhibits extensive genetic variability. We sought to determine whether multiple CMV strains can be transmitted to the fetus and to describe the distribution of genotypes in the saliva, urine, and blood. METHODS Study subjects consisted of a convenience sampling of 28 infants found to be CMV-positive on newborn screening as part of an ongoing study. Genotyping was performed on saliva specimens obtained during newborn screening and urine, saliva, and blood obtained at a later time point within the first 3 weeks of life. RESULTS Six (21.4%) of the 28 saliva samples obtained within the first 2 days of life contained >1 CMV genotype. Multiple CMV genotypes were found in 39% (5/13) of urine, saliva, and blood samples obtained within the first 3 weeks of life from 13 of the 28 newborns. There was no predominance of a CMV genotype at a specific site; however, 4 infants demonstrated distinct CMV strains in different compartments. CONCLUSIONS Infection with multiple CMV strains occurs in infants with congenital CMV infection. The impact of intrauterine infection with multiple virus strains on the pathogenesis and long-term outcome remains to be elucidated.


Infectious disorders drug targets | 2011

Overview of the diagnosis of cytomegalovirus infection.

Shannon A. Ross; Zdenek Novak; Sunil Pati; Suresh B. Boppana

Cytomegalovirus (CMV) is recognized as the most common congenital viral infection in humans and an important cause of morbidity and mortality in immunocompromised hosts. This recognition of the clinical importance of invasive CMV disease in the setting of immunodeficiency and in children with congenital CMV infection has led to the development of new diagnostic procedures for the rapid identification of CMV. Diagnosis of acute maternal CMV infection by the presence of immunoglobulin (Ig)M and low-avidity IgG requires confirmation of fetal infection, which is typically performed using polymerase chain reaction (PCR) assays for CMV on amniotic fluid. Viral culture of the urine and saliva obtained within the first two weeks of life continues to be the gold standard for diagnosis of congenitally-infected infants. PCR assays of dried blood spots from newborns have been shown to lack sufficient sensitivity for the identification of most neonates with congenital CMV infection for universal screening purposes. However, saliva PCR assays are currently being assessed as a useful screening method for congenital CMV infection. In the immunocompromised host, newer rapid diagnostic assays, such as phosphoprotein 65 antigenemia and CMV real-time PCR of blood or plasma have allowed for preemptive treatment, reducing morbidity and mortality. However, lack of standardized real-time PCR protocols hinders the comparison of data from different centers and the development of uniform guidelines for the management of invasive CMV infections in immunocompromised individuals.


Pediatric Infectious Disease Journal | 2008

Congenital cytomegalovirus infection in a highly seropositive semi-urban population in India.

Lalit Dar; Sunil Pati; A. Raj Kumar Patro; Ashok K. Deorari; Sanjay K. Rai; Shashi Kant; Shobha Broor; Karen B. Fowler; William J. Britt; Suresh B. Boppana

To determine the incidence and natural history of congenital cytomegalovirus (CMV) infection in a population of women with near universal serologic reactivity for CMV, a prospective study of 423 women attending the antenatal clinic of the Comprehensive Rural Health Center in northern India was conducted. All 9 (2.1%) CMV positive infants were born to mothers who were CMV seropositive at the first antenatal visit. One child had hepatosplenomegaly at birth and another child had mild unilateral hearing loss at 4 months of age.


International Journal of Gynecological Pathology | 2008

Human papillomavirus-type distribution in women with and without cervical neoplasia in north India.

Neerja Bhatla; Lalit Dar; A. Rajkumar Patro; Pankaj Kumar; Sunil Pati; Alka Kriplani; Arti Gulati; Shobha Broor; Venkateswaran K. Iyer; Sandeep Mathur; Keerti V. Shah; Patti E. Gravitt

Our objective was to determine the human papillomavirus (HPV)-type prevalence in cervical samples in women with and without cervical neoplasia in an opportunistic hospital-based cancer-screening program. A cross-sectional study of 524 women presenting from January 2003 through June 2005 with symptoms of persistent vaginal discharge, intermenstrual bleeding, and postcoital bleeding or detected to have an unhealthy cervix underwent HPV genotyping by consensus polymerase chain reaction and reverse line-blot hybridization assay, conventional Pap smear, and colposcopy, with directed biopsy from all lesions detected. The prevalence rates of HPV infection among women with normal, low-grade cervical neoplasia (CIN 1) and high-grade CIN (>CIN2) were found to be 7.6%, 42.3%, and 87.5%, respectively. Seventeen high-risk and 6 low-risk HPV types were identified by the reverse line-blot assay. Multiple infections were seen in 20% of women. In normal women, the 6 commonest types were HPV-16, HPV-89, HPV-39, HPV-52, HPV-62, and HPV-18, whereas in high-grade disease, these were all high-risk types HPV-16, HPV-18, HPV-33, HPV-39, HPV-35, and HPV-56. HPV-16 was the commonest type in all groups, seen in 49.4% cases overall and in 74.3% of high-grade squamous intraepithelial lesion. It was followed by HPV-18 (7.4%) and HPV-33 and HPV-39 (4.9% each). HPV-89 was the commonest low-risk type (9.9%). HPV-16/18 were associated with 34.3% of normal, 45.4% of low-grade and 65.7% of high-grade lesions. A wide spectrum of HPV types is seen in north Indian women, with the majority being HPV-16 in all grades of histology. A vaccine against HPV-16 and HPV-18 could prevent two thirds of cases of high-grade cervical neoplasia.


Clinical and Vaccine Immunology | 2009

Enzyme-Linked Immunosorbent Assay Method for Detection of Cytomegalovirus Strain-Specific Antibody Responses

Zdenek Novak; Shannon A. Ross; Raj Kumar Patro; Sunil Pati; Meera K. Reddy; Misty Purser; William J. Britt; Suresh B. Boppana

ABSTRACT Reliable methods for the detection of cytomegalovirus (CMV) strain-specific serological responses are lacking. We describe a simple and reliable enzyme-linked immunosorbent assay method developed to detect antibodies against the polymorphic epitopes within the two envelope glycoproteins of CMV, glycoproteins H and B. This assay is useful for the detection of serologic responses to CMV strains and the identification of CMV reinfections.


Scandinavian Journal of Gastroenterology | 2009

High frequency of parasitic and viral stool pathogens in patients with active ulcerative colitis: report from a tropical country.

Debabrata Banerjee; Rachana Deb; Lalit Dar; Bijay Ranjan Mirdha; Sunil Pati; Sandeep Thareja; Sushil Falodia; Vineet Ahuja

Objective. Diarrhoeal relapses in patients with ulcerative colitis (UC) may be associated with enteric infections and its diagnosis may lessen avoidable exposure to corticosteroids and/or immunosuppressants. The purpose of this study was to assess the frequency of stool pathogens (parasitic and viral) in patients with active UC. Material and methods. This prospective cross-sectional study included 49 consecutive patients (32 M, 17 F, mean age 35.8±12 years) with active UC. Three stool samples were collected from each patient and examined for parasitic infection. Rectal biopsies were obtained during sigmoidoscopy to demonstrate cytomegalovirus (CMV) inclusion bodies and to conduct qualitative polymerase chain reaction (PCR) for CMV and herpes simplex virus (HSV) DNA detection. Results. Median duration of illness was 3.9±3.7 years and 83.7% of the patients had moderate to severe disease. The prevalence of parasitic infections in UC was 12%. The organisms isolated were Strongyloides stercoralis in 4%, Ankylostoma duodenale in 4%, Cryptosporidium in 2% and Entamoeba histolytica in 2% of the patients. The prevalence of CMV and HSV in rectal biopsies using qualitative PCR was 8% and 10%, respectively. No predictive factor was identified with CMV superinfection in patients with active UC. Conclusions. In India there is a high prevalence of parasitic and viral infections in patients with active UC. The results of the study suggest that, in tropical countries with a known high prevalence of parasitic diseases, aggressive evaluation for parasitic and viral infections should be carried out, as early identification and prompt treatment of such infections can improve the clinical course of patients with active UC.


Pediatric Infectious Disease Journal | 2013

Genotypic diversity and mixed infection in newborn disease and hearing loss in congenital cytomegalovirus infection.

Sunil Pati; Swetha G. Pinninti; Zdenek Novak; Nazma Chowdhury; Raj K. Patro; Karen B. Fowler; Shannon A. Ross; Suresh B. Boppana

Background: Congenital cytomegalovirus (cCMV) is a common congenital infection and a leading nongenetic cause of sensorineural hearing loss (SNHL). CMV exhibits extensive genetic variability, and infection with multiple CMV strains (mixed infection) was shown to be common in congenital CMV. The role of mixed infections in disease and outcome remains to be defined. Methods: Genotyping of envelope glycoproteins, UL55 (gB), UL73 (gN) and UL75 (gH), was performed on saliva specimens of 79 infants from the ongoing CMV and Hearing Multicenter Screening (CHIMES) Study and on blood and urine specimens of 52 infants who participated in natural history studies at the University of Alabama at Birmingham. Genotyping of UL144 and US28 was also performed in the CHIMES cohort. The association of individual genotypes and mixed infection with clinical findings at birth and SNHL was examined. Results: Thirty-seven of 131 infants (28%) were symptomatic at birth and 26 (20%) had SNHL at birth. All known genotypes of UL55, UL75, UL73 and US28 were represented, and no particular genotype was associated with symptomatic infection or SNHL. UL144 subtype C was more common in symptomatic infants but not associated with SNHL. Mixed infection was observed in 59 infants (45%) and not associated with symptoms (P = 0.43) or SNHL at birth (P = 0.82). In the cohort of 52 infants with long-term hearing outcome, mixed infection at birth was not predictive of SNHL. Conclusions: Mixed infection is common in infants with congenital CMV but is neither associated with symptomatic infection nor associated with SNHL.


Clinical and Vaccine Immunology | 2012

Strain-Specific Neutralizing Antibody Responses against Human Cytomegalovirus Envelope Glycoprotein N

Sunil Pati; Zdenek Novak; Misty Purser; Nitin Arora; Michael Mach; William J. Britt; Suresh B. Boppana

ABSTRACT The human cytomegalovirus (HCMV) gM-gN complex is a major target of virus-neutralizing activity, and gN subtypes induce strain-specific antibodies. However, the biological significance of HCMV gN polymorphisms is not known. Neutralizing antibody responses against HCMV gN recombinant viruses were investigated at study entry in 80 healthy HCMV-seropositive women who were monitored for the appearance of new antibody specificities against linear strain-specific epitopes on glycoproteins gH and gB as evidence of HCMV reinfection. Neutralizing activity against all four gN recombinant viruses was seen in 74% of subjects, and 61% of subjects had strain-specific responses. Significantly fewer women (9/39 subjects [23%]) with serological evidence of reinfection had strain-specific neutralizing responses than the women without reinfection (21/41 subjects [51%]). Women with antibodies against at least one of the four linear gB and gH antigens at study entry had higher neutralizing titers against gN-1 (P = 0.006) and gN-2 (P = 0.007). Neutralizing titers of ≥400 against gN-3 (P = 0.043) and gN-4 (P = 0.049) at study entry were associated with longer times to serological evidence of reinfection. The findings demonstrate that HCMV gN elicits strain-specific neutralizing antibody responses and that broader anti-gN neutralizing activity may provide some protection from reinfection with a different virus strain.


Journal of Clinical Microbiology | 2011

Diagnostic consequences of cytomegalovirus glycoprotein B polymorphisms

Zdenek Novak; Nazma Chowdhury; Shannon A. Ross; Sunil Pati; Karen B. Fowler; Suresh B. Boppana

ABSTRACT Failure of a cytomegalovirus (CMV) real-time PCR assay targeting glycoprotein B (gB) was investigated. A multiplex assay targeting gB and immediate-early 2 (IE2) genes showed discordant results (gB negative and IE positive or a >10-fold-higher viral load with IE primers) in saliva from 14.6% of CMV-infected newborns. Sequencing revealed 3 patterns of gB variations.

Collaboration


Dive into the Sunil Pati's collaboration.

Top Co-Authors

Avatar

Suresh B. Boppana

University of Alabama at Birmingham

View shared research outputs
Top Co-Authors

Avatar

Shannon A. Ross

University of Alabama at Birmingham

View shared research outputs
Top Co-Authors

Avatar

Zdenek Novak

University of Alabama at Birmingham

View shared research outputs
Top Co-Authors

Avatar

Karen B. Fowler

University of Alabama at Birmingham

View shared research outputs
Top Co-Authors

Avatar

William J. Britt

University of Alabama at Birmingham

View shared research outputs
Top Co-Authors

Avatar

Lalit Dar

All India Institute of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Shobha Broor

All India Institute of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Nazma Chowdhury

University of Alabama at Birmingham

View shared research outputs
Top Co-Authors

Avatar

A. Raj Kumar Patro

All India Institute of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Raj Kumar Patro

All India Institute of Medical Sciences

View shared research outputs
Researchain Logo
Decentralizing Knowledge